Smaller portions, more protein: How GLP-1s are quietly changing chain restaurant menus

NBC News • January 19, 2026 • business

Key Points:

National restaurant chains are redesigning menus to offer smaller portions and higher-protein options at lower prices, responding to the growing use of GLP-1 medications that suppress appetite and encourage nutrient-dense meals.
GLP-1 drugs like Zepbound and Wegovy, initially for diabetes, have become popular weight-loss aids, prompting chains such as Olive Garden, Chipotle, and Subway to introduce lighter, protein-focused menu items.
The shift toward protein-rich, smaller-portion meals aligns with updated U.S. dietary guidelines recommending increased protein intake, as well as changing consumer preferences influenced by GLP-1 use and broader health trends.
Restaurant executives acknowledge that GLP-1 medication use is a significant factor driving demand